BzODZ-EPyr
 | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| PubChem (CID) | 9842447 |
| ChemSpider | 8018162 |
| ChEMBL | CHEMBL463656 |
| Chemical and physical data | |
| Formula | C23H24N4O |
| Molar mass | 372.47 g·mol−1 |
| 3D model (Jmol) | Interactive image |
| |
| |
BzODZ-EPyr is an indole based synthetic cannabinoid that has been sold as a designer drug in Russia.[1]
It acts as a CB1 receptor agonist with a pKB value of 7.2 and demonstrates that replacing the ketone in 3-carbonylindoles with an oxadiazole spacer does generally not lead to activity loss.[2][3]
See also
References
- ↑ Shevyrin, Vadim; Melkozerov, Vladimir; Eltsov, Oleg; Shafran, Yuri; Morzherin, Yuri (February 2016). "Synthetic cannabinoid 3-benzyl-5-[1-(2-pyrrolidin-1-ylethyl)-1H-indol-3-yl]-1,2,4-oxadiazole. The first detection in illicit market of new psychoactive substances". Forensic Science International. 259: 95–100. doi:10.1016/j.forsciint.2015.12.019. PMID 26771874.
- ↑ Moloney, Gerard P.; Angus, James A.; Robertson, Alan D.; Stoermer, Martin J.; Robinson, Michael; Wright, Christine E.; McRae, Ken; Christopoulos, Arthur (March 2008). "Synthesis and cannabinoid activity of 1-substituted-indole-3-oxadiazole derivatives: Novel agonists for the CB1 receptor". European Journal of Medicinal Chemistry. 43 (3): 513–539. doi:10.1016/j.ejmech.2007.04.007. PMID 17582659.
- ↑ Moloney, Peter Gerard; Robertson, Alan Duncan (2005), "Patent US6930118 - 3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives", Amrad Operations Pty. Ltd.
This article is issued from Wikipedia - version of the 8/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.